Antibacterial strategies | Nanocarriers | Tested microorganism | Therapeutic effects | Refs. |
---|---|---|---|---|
Antibiotic delivery | MSNConA@LEVO | E. coli | Effective penetration in Gram-negative bacterial biofilm | [66] |
PMB^B/N/C-MSN | E. coli | High loading capacity, enhance antibacterial activity | [68] | |
MSN-NH2-CEF/MEP | A. baumannii | Enhance bactericidal activity, reduce side effects and toxicity | [69] | |
Silver-incorporated | CCM@SBA-15/PDA/Ag | E. coli, S. aureus | Reduce side effects, enhance Gram-negative bacterial killing | [72] |
MSN-Ag-DNase I | E. coli, S. mutans | Enhance bacterial biofilm eradication | [73] | |
Copper-incorporated | SBA-CuO | E. coli | Stronger antibacterial properties | [76] |
MSN-maleamic-Cu | E. coli S. aureus | Exhibiting a powerful antibacterial effect | [78] | |
AZOX@MSNs-PDA-Cu | Pyricularia oryzae | Provides a new way to design antibacterial agents | [79] | |
Zinc-incorporated | ZnO-SBA-15 | E. coli | Coordination effect assist for anti-bacterial application | [85] |
ZnO-SiO2 | Candida albicans, S. aureus | Reduce nanoparticle retention risk in host and environment | [86] | |
Cationic polymer-grated | Spiky silica nanocomposite I | Staphylacoccus Epidermidis | Enhanced anti-microbial and anti-biofilm properties | [88] |
Antibacterial peptide-grafted | MSNs@OVTp12@Gen | E. coli | Treatment of bacterial infections effectively and prevention of bacterial drug resistance | [93] |
MSN@T7E21R@HD5@SCN | E. coli | Promising oral antibacterial formulation against E. coli | [95] |